cerrar
Tagged with DIA

Aligning Stakeholder Partnerships in Latin America: Best…
Writing in the November issue of DIA Global Forum, Lawrence Liberti, Mario Alanis, Pravin Chopra, and Silvia Bendiner examine how the COVID-19…

Australia Aiming Targeted Therapies Toward Truly Personalised…
In conversation in the November issue of DIA’s Global Forum magazine, Australian Pharmaceutical medical and scientific Professionals Association…

Umut Ağyüz – Founder & CEO, Genz Biotechnology
Genz Biotechnology is a biotech startup working on novel diagnostic testing solutions. Its founder and CEO, Umut Ağyüz, explains the origins of…

Kasper Bødker Mejlvang – General Manager, Novo Nordisk…
Kasper Bødker Mejlvang oversees Novo Nordisk’s operations in its historic home market of Denmark, as well as Iceland. Here, Bødker Mejlvang…

Peptides: Technological Maturity Leading to Big Investments…
With advances in technology, an increasing number of stable peptide-based therapeutics are being brought to market today across a wide range of…

Yelda Ulu Colin – Managing Director Turkey, Iran,…
General manager of Core Diagnostic at Abbott Turkey Yelda Ulu Colin highlights the company's prominent role during the pandemic, including the launch…

Emmanuel Dulac – President & CEO, Zealand Pharma
Zealand Pharma’s Emmanuel Dulac, fresh from a first US FDA approval for the company’s rescue pen for severe hypoglycaemia in people with diabetes…

Navin Pinto – Attending Physician, Seattle Children’s…
Paediatric oncologist Navin Pinto, MD outlines the current use and potential of CAR-T therapies in his field, including the manufacturing challenges…

CADTH CEO Suzanne McGurn on the Key Challenges in HTA Today
In conversation in the October edition of DIA’s Global Forum magazine, Canadian Agency for Drugs and Technologies in Health (CADTH) CEO Suzanne…

India Pharma News: Piramal Demerges Pharma Business; Lundbeck…
The latest news from Indian pharm and healthcare, including Piramal Enterprises’ decision to demerge and list its pharma arm, the country’s 15…

Lilly Signs Saudi MoU for Insulin Manufacturing
Saudi Arabia has one of the highest rates of diabetes in the world – over 17 percent of the population are diabetic – making the supply of insulin…

Regulatory Cooperation & Joint Assessments in ASEAN
Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia's National Pharmaceutical Regulatory Agency;…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here